ArticleThe Lancet. Oncology2024

Effectiveness and safety of immune checkpoint inhibitors in Black patients versus White patients in a US national health system: a retrospective cohort study.

Sean Miller et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.